Last updated: 5 September 2024 at 4:12pm EST

Andrew Turitz Net Worth




The estimated Net Worth of Andrew Turitz is at least $4.99 Million dollars as of 4 September 2024. Mr. Turitz owns over 20,773 units of Teladoc Health Inc stock worth over $151,643 and over the last 7 years he sold TDOC stock worth over $4,838,609. In addition, he makes $0 as Senior Vice President of Business Development at Teladoc Health Inc.

Mr. Turitz TDOC stock SEC Form 4 insiders trading

Andrew has made over 35 trades of the Teladoc Health Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 20,773 units of TDOC stock worth $150,812 on 4 September 2024.

The largest trade he's ever made was selling 36,210 units of Teladoc Health Inc stock on 2 March 2018 worth over $1,462,522. On average, Andrew trades about 6,456 units every 57 days since 2018. As of 4 September 2024 he still owns at least 20,773 units of Teladoc Health Inc stock.

You can see the complete history of Mr. Turitz stock trades at the bottom of the page.





Andrew Turitz biography

Andrew Turitz serves as Senior Vice President of Business Development of the Company since January 2015. He is responsible for identifying, evaluating and executing growth opportunities for Teladoc Health through partnerships, acquisitions, joint ventures and other third-party relationships. From 2012 through 2015, Mr. Turitz served as Managing Director of Healthagen, a division of Aetna’s health and technology services unit, after serving as Managing Director of Blue Cross Blue Shield Ventures. Mr. Turitz has nearly 15 years of experience in healthcare transactions, including the management of all phases of acquisitions, investments and partnerships?—?from analysis, diligence and transaction structuring to product integration, go-to-market strategies and operational implementation. Mr. Turitz has advised on mergers and acquisitions transactions for Fortune 500 companies, and led investments in and served on the board of directors for venture-backed companies. He is also an entrepreneur that has launched or joined numerous early-stage businesses. Mr. Turitz holds a B.A. from Stanford University and a M.B.A. from the Kellogg School of Management at Northwestern University.



How old is Andrew Turitz?

Andrew Turitz is 47, he's been the Senior Vice President of Business Development of Teladoc Health Inc since 2015. There are 20 older and 2 younger executives at Teladoc Health Inc. The oldest executive at Teladoc Health Inc is David Shedlarz, 71, who is the Independent Director.

What's Andrew Turitz's mailing address?

Andrew's mailing address filed with the SEC is C/O TELADOC HEALTH, INC.,, 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE, NY, 10577.

Insiders trading at Teladoc Health Inc

Over the last 9 years, insiders at Teladoc Health Inc have traded over $190,385,368 worth of Teladoc Health Inc stock and bought 50,333 units worth $544,816 . The most active insiders traders include Hemant Taneja, Glen Tullman, and Jason N Gorevic. On average, Teladoc Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of $111,413. The most recent stock trade was executed by Andrew Turitz on 4 September 2024, trading 20,773 units of TDOC stock currently worth $150,812.



What does Teladoc Health Inc do?

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked best in KLAS for Virtual Care Platforms in 2020, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals.



What does Teladoc Health Inc's logo look like?

Teladoc Health Inc logo

Complete history of Mr. Turitz stock trades at Teladoc Health Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
4 Sep 2024 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Sale 20,773 $7.26 $150,812
4 Sep 2024
20,773
30 Aug 2024 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 5,504 $7.17 $39,464
30 Aug 2024
43,163
31 May 2024 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 5,504 $11.24 $61,865
31 May 2024
39,286
5 Mar 2024 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Sale 5,647 $14.53 $82,051
5 Mar 2024
33,782
1 Mar 2024 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 20,426 $15.00 $306,390
1 Mar 2024
45,619
1 Dec 2023 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 1,347 $18.97 $25,553
1 Dec 2023
26,065
1 Sep 2023 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 1,347 $22.87 $30,806
1 Sep 2023
25,114
1 Jun 2023 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 1,347 $23.83 $32,099
1 Jun 2023
24,153
3 Mar 2023 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Sale 1,795 $25.91 $46,508
3 Mar 2023
22,806
1 Mar 2023 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 11,608 $25.88 $300,415
1 Mar 2023
24,601
4 Mar 2022 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 4,541 $66.78 $303,248
4 Mar 2022
16,128
2 Mar 2022 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 5,785 $72.49 $419,355
2 Mar 2022
13,341
5 Mar 2021 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Sale 3,859 $186.17 $718,430
5 Mar 2021
7,556
3 Mar 2021 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 6,397 $203.19 $1,299,806
3 Mar 2021
11,415
1 Mar 2021 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 5,558 $223.39 $1,241,602
1 Mar 2021
8,878
3 Dec 2020 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 1,389 $22.30 $30,975
3 Dec 2020
5,404
4 Nov 2020 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 1,389 $22.30 $30,975
4 Nov 2020
5,404
2 Oct 2020 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 2,106 $27.83 $58,610
2 Oct 2020
5,404
2 Sep 2020 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 2,107 $27.83 $58,638
2 Sep 2020
5,405
3 Aug 2020 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 2,105 $27.83 $58,582
3 Aug 2020
6,120
8 Jul 2020 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 5,017 $38.55 $193,405
8 Jul 2020
9,032
6 Jul 2020 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 1,389 $22.30 $30,975
6 Jul 2020
5,404
19 Jun 2020 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 2,778 $22.30 $61,949
19 Jun 2020
6,793
16 Apr 2020 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Sale 14,122 $168.41 $2,378,286
16 Apr 2020
3,986
5 Mar 2020 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 4,541 $134.33 $609,993
5 Mar 2020
10,279
2 Mar 2020 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 4,161 $124.49 $518,003
2 Mar 2020
7,429
9 Dec 2019 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 9,158 $22.99 $210,542
9 Dec 2019
13,144
9 Sep 2019 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 9,158 $22.98 $210,451
9 Sep 2019
13,144
17 Jun 2019 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 9,157 $22.99 $210,519
17 Jun 2019
13,143
4 Apr 2019 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 31,960 $23.68 $756,813
4 Apr 2019
35,946
18 Dec 2018 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 2,734 $6.01 $16,431
18 Dec 2018
3,910
3 Dec 2018 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 8,202 $6.01 $49,294
3 Dec 2018
9,378
4 Sep 2018 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 8,202 $6.01 $49,294
4 Sep 2018
9,378
3 Jul 2018 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Option 13,821 $10.56 $145,950
3 Jul 2018
14,997
2 Mar 2018 Andrew Turitz
EVP and CORPORATE DEVELOPMENT
Sale 36,210 $40.39 $1,462,522
2 Mar 2018
0


Teladoc Health Inc executives and stock owners

Teladoc Health Inc executives and other stock owners filed with the SEC include: